Hints and tips:
...Corporate earnings: Companies set to report include Indian pharmaceuticals company Dr Reddy’s Laboratories, tech platform Grab and Chinese electronics manufacturer Xiaomi....
...Letter in response to this article: A child psychiatrist is something very different / From Dr Joel S Richman, Grey-haired Clinical Psychologist, Hoffman Estates, IL, US...
...JAB’s $19bn acquisition last month of carbonated drinks maker Dr Pepper Snapple also positions it strongly to expand in the rapidly growing US “ready to drink” coffee market....
...Indivior vowed to appeal a ruling from the US District Court for the District of Delaware, which said that a proposed generic opioid addiction treatment by Dr Reddy’s does not infringe any of Indivior’s...
...Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC; Apotex Corp.; Dr....
...Insert Dr. Evil meme here....
...Letters in response to this article: Infringers handed new tools to attack patents / From Frederick S Burkhart, Grand Rapids, MI, US An innovative approach to intellectual property / From Dr Richard Rohwer...
...Dell’s shareholders, seeking a higher price, retained Bradford Cornell of Caltech, the university that is home to Nasa’s rocket laboratory....
...Dr Reddy's launched a rival US version of Nexium in September but a Delaware court placed a temporary block on sales on Tuesday after AstraZeneca filed a motion objecting to the purple colour of the Indian...
...The S&P 500 closed 0.1 per cent higher at 2,039.68, the Dow Jones Industrial Average was flat at 17,614.90. The Nasdaq Composite rose 0.2 per cent to 4,660.56....
...Dr Reddy’s, Fujifilm in pact for Japan generic drugs JV Dr....
...He said Dr Reddy’s had considered alternative sites for European expansion in Germany and in Switzerland....
...The son-in-law of Dr Reddy’s founder Anji Reddy, Mr Prasad wants to build on Cambridge-based Chirotech, a modest-sized deal sealed in 2008, which strengthens Dr Reddy’s technical expertise and low-cost production...
...GlaxoSmithKline has an agreement with Dr Reddy’s Laboratories to collaborate in emerging markets....
...Other groups that have sealed partnerships include GlaxoSmithKline with Dr Reddy’s Laboratories, and Pfizer with Aurobindo and Claris Lifesciences....
...Other companies have sought to forge partnerships to exploit local companies’ commercial presence and skills in manufacturing, including GlaxoSmithKline and Dr Reddy’s, and Pfizer with Aurobindo and Claris...
...Revenues will be reported by Glaxo and shared with Dr Reddy’s under terms that the companies are not disclosing. In some undisclosed markets, Dr Reddy’s and GSK will co-market drugs....
...Lennar gained 11.7 per cent to $8.69, while KB Home picked up 10.5 per cent to $15.75 and DR Horton rose 8.2 per cent to $11.16....
...Led by Cipla, Ranbaxy and Dr Reddy’s, they are now keen to expand abroad to maintain their growth in countries including in the US, the world’s largest medicines market....
...Indian drugmakers such as Ranbaxy and Dr Reddy’s are known as manufacturers of cheap generic drugs but they are racing to develop original medicines with their own teams of scientists....
...It is home to Dr Reddy’s Laboratories, the country’s largest drugs group by sales, and to Satyam Computer Services, India’s fourth-biggest computer software exporter....
...Dr Reddy’s, another big generics maker, recently formed Perlecan Pharma, a joint venture with Citigroup and ICICI, India’s largest private bank, to finance some R&D....
...Dr Reddy’s Laboratories, one of India’s largest drugmakers, seeks to raise about $262m through a share sale in the US and may use proceeds for expansion, more acquisitions or investment in technology....
International Edition